查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球糖组学市场，到 2030 年的市场预测：按产品、用途、最终用户和地区进行的全球分析
市场调查报告书
商品编码
1372016

全球糖组学市场，到 2030 年的市场预测：按产品、用途、最终用户和地区进行的全球分析

Glycomics Market Forecasts to 2030 - Global Analysis By Product (Kits, Reagents, Enzymes and Instruments), Application (Diagnostics, Drug Discovery & Development and Other Applications), End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球糖组学市场规模为 21.3 亿美元，预计到 2030 年将达到 66.1 亿美元，预测期内年复合成长率为 17.5%。

糖组学是分子生物学和生物化学的一个领域，专注于生命系统中碳水化合物（糖）的结构、功能和生物学的综合分析。它涉及复杂碳水化合物（称为聚醣）及其与细胞和生物体中其他分子的相互作用的研究。该研究具有广泛的意义，包括了解生物过程、阐明疾病机制和开发新的治疗方法。

哥本哈根大学糖组学中心的研究人员在 2022 年 2 月发表的一项研究表明，醣组学研究使得在不使用动物的情况下生产肝素成为可能。

糖组学研究的兴起

越来越多的糖组学研究揭示了聚醣在各种生物过程、疾病和治疗开发中的重要作用。这种广泛的范围正在为跨生物医学应用的糖组学技术创造更广泛的市场。糖组学研究的增加促进了分析技术的创新。随着研究的不断增加，对更容易获得和更具成本效益的糖组学技术的需求不断增长。它还创造了对专业工具、技术和服务的强劲需求。这些方面正在推动市场成长。

有限的标准化

聚醣是高度多样化且结构复杂的分子。在不同的研究环境和实验室中标准化聚醣分析和表征非常困难，并且可能导致资料解释中潜在的不一致和困难。此外，有限的商业性标准、多样化的分析技术、环境要素、结构多样性和演化多样性阻碍了市场需求。

癌症生物标记和诊断的增加

醣组学研究在识别与不同类型癌症相关的特异性聚醣结构方面发挥着重要作用。了解这些独特的聚醣模式有助于开发准确可靠的癌症生物标记。这提高了癌症亚型分类的准确性。醣组学研究也可能导致发现与特定癌症类型相关的多种聚醣生物标记。透过将这些标记物组合成一个群组，可以进一步提高诊断准确性。此外，改善癌症检测、治疗和患者治疗结果的实际意义正在推动市场成长。

设备和试剂高成本

研究机构，尤其是预算有限的研究和学术机构，在取得和维护必要的糖组学设备和试剂方面可能面临挑战。这减慢了研究的步伐，甚至让一些实验室对于进入该领域犹豫不决。设备和试剂的高成本也可能阻碍公司和製造商投资糖组学技术的研发。因此，高昂的进入成本可能会减缓糖组学市场的成长。

COVID-19 的影响

COVID-19大流行对糖组学领域产生了直接和间接的影响。由于关闭、限制和安全措施，许多实验室和研究机构的业务面临中断。大流行的经济影响对研究经费产生了长期影响。从正面的一面来看，这场大流行凸显了了解聚醣在病毒感染中的作用的重要性。研究人员正在探索聚醣在开发与 COVID-19 相关的疗法、疫苗或诊断方面的潜力。

预计套件细分市场在预测期内将是最大的

套件领域预计将出现良好的增长。糖组学试剂盒是专门的试剂、工具和方案集，旨在促进生物检体中复杂碳水化合物（聚醣）的分析和研究。我们提供一套标准化试剂和方法，用于全面分析生物检体中的聚醣。醣组学试剂盒包含酵素、标记剂以及酵素释放和修饰聚醣以进行详细结构分析所需的其他工具。这些在生物製药的诊断和品管中发挥着重要作用。

预计药物研发和开发领域在预测期内的年复合成长率最高。

在预测期内，药物研发和开发领域预计将以最高年复合成长率成长。将糖组学整合到药物研发和开发过程中可以实现更准确、更有效的治疗，透过改善治疗结果和最大限度地减少副作用最终使患者受益。糖组学有助于药物设计，减少脱靶效应并提高选择性。它还可以提高疫苗效率。所有这些要素都在推动该领域的成长。

比最大的地区

预计北美在预测期内将占据最大的市场占有率。北美由美国和加拿大结构，是世界上最大的糖组市场之一。北美拥有许多着名的研究机构、大学和学术医疗中心。该地区先进的医疗保健基础设施、强大的研究生态系统以及对生物技术和生命科学的大量投资正在促进市场的规模和成长。

复合年复合成长率最高的地区

预计亚太地区在预测期内的年复合成长率最高。亚太糖组学市场是全球生物技术公司、学术研究机构和本地製造商的混合体。老牌企业和新兴新兴企业都在为竞争形势做出贡献。亚太地区的生物製药产业正在迅速扩张。医疗保健产业向个人化医疗的转变正在推动该地区对糖组学技术的需求。

提供免费客製化

订阅此报告的客户可以利用以下免费自订选项之一：

  • 公司简介
    • 其他市场公司的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和年复合成长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第1章执行摘要

第2章前言

  • 概述
  • 利害关係人
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究来源
    • 主要研究来源
    • 二次研究来源
    • 先决条件

第3章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第5章全球糖组学市场：副产品

  • 成套工具
    • 聚醣标记试剂盒
    • 聚醣精製盒
    • 聚醣释放套件
    • 其他糖组学试剂盒
  • 试剂
    • 糖蛋白
    • 单醣
    • 寡糖
    • 其他试剂
  • 酵素
    • 糖苷酶
    • 糖基转移酶
    • 神经氨酸酶
    • 唾液酸转移酶
    • 其他酵素
  • 装置
    • 高效液相层析（HPLC）
    • 基质辅助雷射解吸/电离飞行时间(MALDI-TOF)
    • 质谱仪
    • 阵列系统
    • 其他设备

第6章全球糖组学市场：依用途

  • 诊断
  • 药物研发/开发
  • 其他用途

第7章全球糖组学市场：依最终用户分类

  • 学术研究所
  • 製药和生物技术公司
  • 生物製药公司
  • 合约研究组织（CRO）

第8章全球糖组学市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东/非洲

第9章进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第10章公司简介

  • Asparia Glycomics
  • Merck KGaA
  • Bruker
  • Thermo Fisher Scientific, Inc
  • New England Biolabs
  • Waters Corporation
  • Takara Bio Inc
  • Agilent Technologies Inc.
  • RayBiotech Life, Inc.
  • Shimadzu Corporation
  • Danaher
  • Lectenz Bio
  • Intellihep Limited
  • Sanofi Corporation
  • Bayer AG
Product Code: SMRC24072

According to Stratistics MRC, the Global Glycomics Market is accounted for $2.13 billion in 2023 and is expected to reach $6.61 billion by 2030 growing at a CAGR of 17.5% during the forecast period. Glycomics is a field of study within molecular biology and biochemistry that focuses on the comprehensive analysis of the structure, function, and biology of carbohydrates (sugars) in biological systems. It involves the study of complex carbohydrates, also known as glycans, and their interactions with other molecules in cells and organisms. Its research has far-reaching implications for understanding of biological processes, disease mechanisms, and the development of novel therapies.

According to a study published in February 2022 by researchers at the University of Copenhagen's Center for Glycomics, Heparin can now be produced without using animals through glycomics studies.

Market Dynamics:

Driver:

Increasing research in glycomics

Growing research in glycomics reveals the critical role of glycans in various biological processes, diseases, and therapeutic development. This broadening scope creates a wider market for glycomics technologies across biomedicine applications. Increased research in glycomics fosters innovation in analytical techniques. With increased research, there is a demand for more accessible and cost-effective glycomics technologies. It also creates a strong demand for specialized tools, technologies, and services. These aspects are propelling the market growth.

Restraint:

Limited standardization

Glycans are highly diverse and structurally complex molecules. Standardizing the analysis and characterization of glycans across different research settings and laboratories can be challenging, leading to potential inconsistencies and difficulties in data interpretation. In addition, its limited commercial standards, varied analytical techniques, environmental factors, structural diversity and evolutionary variabilites hinder the market demand.

Opportunity:

Rising cancer biomarkers and diagnostics

Glycomics research plays a crucial role in identifying specific glycan structures associated with various types of cancer. Understanding these unique glycan patterns allows for the development of accurate and reliable cancer biomarkers. It improves precision in cancer subtyping. Also, glycomics research may lead to the discovery of multiple glycan biomarkers associated with a specific cancer type. Combining these markers into a panel can further enhance diagnostic accuracy. Further, its practical implications for improving cancer detection, treatment, and patient outcomes are accelerating the market growth.

Threat:

High cost of instruments and reagents

Research labs, particularly those with limited budgets or in academic settings, may face challenges in acquiring and maintaining the necessary glycomics equipment and reagents. This can lead to a slower pace of research or even deter some labs from entering the field. The high cost of instruments and reagents may deter companies and manufacturers from investing in research and development for glycomics technologies. Therefore, the high cost of entry can potentially slow down the growth of the glycomics market.

COVID-19 Impact

The COVID-19 pandemic had both direct and indirect impacts on the field of Glycomics. Many research laboratories and institutions faced disruptions in their operations due to lockdowns, restrictions, and safety measures. The financial impact of the pandemic had a long-term effect on research funding. On the positive side, the pandemic highlighted the importance of understanding the role of glycans in viral infections. Researchers have explored the potential of glycans in the development of therapeutics, vaccines, or diagnostics related to COVID-19.

The kits segment is expected to be the largest during the forecast period

The kits segment is estimated to have a lucrative growth. Glycomics kits are specialized sets of reagents, tools, and protocols designed to facilitate the analysis and study of complex carbohydrates (glycans) in biological samples. They provide a standardized set of reagents and methods for the comprehensive profiling of glycans in biological samples. Glycomics kits include enzymes, labeling agents, and other tools necessary for the enzymatic release and modification of glycans, enabling detailed structural analysis. They play a crucial role in the diagnostics and quality control in biopharmaceuticals.

The drug discovery & development segment is expected to have the highest CAGR during the forecast period

The drug discovery & development segment is anticipated to witness the highest CAGR growth during the forecast period. The integration of glycomics into drug discovery and development processes leads to more precise and effective therapies, ultimately benefiting patients by improving treatment outcomes and minimizing side effects. Glycomics can contribute to the design of drugs with reduced off-target effects and improved selectivity. It can also improve vaccine efficiency. All these factors are driving the segment growth.

Region with largest share:

North America is projected to hold the largest market share during the forecast period. North America, comprising the United States and Canada, represented one of the largest glycomics markets globally. North America is home to numerous prominent research institutions, universities, and academic medical centers. The region's advanced healthcare infrastructure, robust research ecosystem, and significant investments in biotechnology and life sciences contributed to the market's size and growth.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR over the forecast period. The Glycomics market in Asia Pacific includes a mix of global biotechnology companies, academic research institutions, and local manufacturers. Both established players and emerging start-ups contribute to the competitive landscape. The biopharmaceutical industry in Asia Pacific is expanding rapidly. The shift towards personalized medicine in the healthcare industry drives the demand for glycomics technologies in this region.

Key players in the market:

Some of the key players profiled in the Glycomics Market include: Asparia Glycomics, Merck KGaA, Bruker, Thermo Fisher Scientific, Inc, New England Biolabs, Waters Corporation, Takara Bio Inc, Agilent Technologies Inc., RayBiotech Life, Inc., Shimadzu Corporation, Danaher, Lectenz Bio, Intellihep Limited, Sanofi Corporation and Bayer AG.

Key Developments:

In August 2023, Thermo Fisher Scientific the world leader in serving science, announced the commercial launch of the EXENT® Solution, after receiving IVDR certification*. The EXENT solution is a fully integrated and automated mass spectrometry system designed to transform diagnosis and assessment for patients with monoclonal gammopathies.

In June 2022, Sanofi announced the launch of its first Digital Accelerator to foster its ambition to become a leading digital healthcare company. The Accelerator will develop products and solutions that will support Sanofi's mission to transform the practice of medicine with the use of digital, data and artificial intelligence (AI).

Products Covered:

  • Kits
  • Reagents
  • Enzymes
  • Instruments

Applications Covered:

  • Diagnostics
  • Drug Discovery & Development
  • Other Applications

End Users Covered:

  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Biopharmaceutical Companies
  • Contract Research Organization (CRO)

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Glycomics Market, By Product

  • 5.1 Introduction
  • 5.2 Kits
    • 5.2.1 Glycan Labeling Kits
    • 5.2.2 Glycan Purification Kits
    • 5.2.3 Glycan Release Kits
    • 5.2.4 Other Glycomics Kits
  • 5.3 Reagents
    • 5.3.1 Glycoproteins
    • 5.3.2 Monosaccharides
    • 5.3.3 Oligosaccharides
    • 5.3.4 Other Reagents
  • 5.4 Enzymes
    • 5.4.1 Glycosidases
    • 5.4.2 Glycosyltransferases
    • 5.4.3 Neuraminidases
    • 5.4.4 Sialyltransferases
    • 5.4.5 Other Enzymes
  • 5.5 Instruments
    • 5.5.1 High-Performance Liquid Chromatography (HPLC)
    • 5.5.2 Matrix-Assisted Laser Desorption/Ionization Time-Of-Flight (MALDI-TOF)
    • 5.5.3 Mass Spectrometers
    • 5.5.4 Array Systems
    • 5.5.5 Other Instruments

6 Global Glycomics Market, By Application

  • 6.1 Introduction
  • 6.2 Diagnostics
  • 6.3 Drug Discovery & Development
  • 6.4 Other Applications

7 Global Glycomics Market, By End User

  • 7.1 Introduction
  • 7.2 Academic & Research Institutes
  • 7.3 Pharmaceutical & Biotechnology Companies
  • 7.4 Biopharmaceutical Companies
  • 7.5 Contract Research Organization (CRO)

8 Global Glycomics Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Asparia Glycomics
  • 10.2 Merck KGaA
  • 10.3 Bruker
  • 10.4 Thermo Fisher Scientific, Inc
  • 10.5 New England Biolabs
  • 10.6 Waters Corporation
  • 10.7 Takara Bio Inc
  • 10.8 Agilent Technologies Inc.
  • 10.9 RayBiotech Life, Inc.
  • 10.10 Shimadzu Corporation
  • 10.11 Danaher
  • 10.12 Lectenz Bio
  • 10.13 Intellihep Limited
  • 10.14 Sanofi Corporation
  • 10.15 Bayer AG

List of Tables

  • Table 1 Global Glycomics Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Glycomics Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Glycomics Market Outlook, By Kits (2021-2030) ($MN)
  • Table 4 Global Glycomics Market Outlook, By Glycan Labeling Kits (2021-2030) ($MN)
  • Table 5 Global Glycomics Market Outlook, By Glycan Purification Kits (2021-2030) ($MN)
  • Table 6 Global Glycomics Market Outlook, By Glycan Release Kits (2021-2030) ($MN)
  • Table 7 Global Glycomics Market Outlook, By Other Glycomics Kits (2021-2030) ($MN)
  • Table 8 Global Glycomics Market Outlook, By Reagents (2021-2030) ($MN)
  • Table 9 Global Glycomics Market Outlook, By Glycoproteins (2021-2030) ($MN)
  • Table 10 Global Glycomics Market Outlook, By Monosaccharides (2021-2030) ($MN)
  • Table 11 Global Glycomics Market Outlook, By Oligosaccharides (2021-2030) ($MN)
  • Table 12 Global Glycomics Market Outlook, By Other Reagents (2021-2030) ($MN)
  • Table 13 Global Glycomics Market Outlook, By Enzymes (2021-2030) ($MN)
  • Table 14 Global Glycomics Market Outlook, By Glycosidases (2021-2030) ($MN)
  • Table 15 Global Glycomics Market Outlook, By Glycosyltransferases (2021-2030) ($MN)
  • Table 16 Global Glycomics Market Outlook, By Neuraminidases (2021-2030) ($MN)
  • Table 17 Global Glycomics Market Outlook, By Sialyltransferases (2021-2030) ($MN)
  • Table 18 Global Glycomics Market Outlook, By Other Enzymes (2021-2030) ($MN)
  • Table 19 Global Glycomics Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 20 Global Glycomics Market Outlook, By High-Performance Liquid Chromatography (HPLC) (2021-2030) ($MN)
  • Table 21 Global Glycomics Market Outlook, By Matrix-Assisted Laser Desorption/Ionization Time-Of-Flight (MALDI-TOF) (2021-2030) ($MN)
  • Table 22 Global Glycomics Market Outlook, By Mass Spectrometers (2021-2030) ($MN)
  • Table 23 Global Glycomics Market Outlook, By Array Systems (2021-2030) ($MN)
  • Table 24 Global Glycomics Market Outlook, By Other Instruments (2021-2030) ($MN)
  • Table 25 Global Glycomics Market Outlook, By Application (2021-2030) ($MN)
  • Table 26 Global Glycomics Market Outlook, By Diagnostics (2021-2030) ($MN)
  • Table 27 Global Glycomics Market Outlook, By Drug Discovery & Development (2021-2030) ($MN)
  • Table 28 Global Glycomics Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 29 Global Glycomics Market Outlook, By End User (2021-2030) ($MN)
  • Table 30 Global Glycomics Market Outlook, By Academic & Research Institutes (2021-2030) ($MN)
  • Table 31 Global Glycomics Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
  • Table 32 Global Glycomics Market Outlook, By Biopharmaceutical Companies (2021-2030) ($MN)
  • Table 33 Global Glycomics Market Outlook, By Contract Research Organization (CRO) (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.